detalle del documento
IDENTIFICACIÓN
oai:pubmedcentral.nih.gov:1036...
Tema
ReviewAutor
Abboud, Tammam Rohde, Veit Mielke, DorotheeLangue
enEditor
BioMed Central
Categoría
BMC Neuroscience
Año
2023
fecha de cotización
11/12/2023
Palabras clave
protein s100bResumen
Prognosticating the clinical outcome of neurological diseases is essential to guide treatment and facilitate decision-making.
It usually depends on clinical and radiological findings.
Biomarkers have been suggested to support this process, as they are deemed objective measures and can express the extent of tissue damage or reflect the degree of inflammation.
Some of them are specific, and some are not.
Few of them, however, reached the stage of daily application in clinical practice.
This mini review covers available applications of the S100B protein in prognosticating clinical outcome in patients with various neurological disorders, particularly in those with traumatic brain injury, spontaneous subarachnoid hemorrhage and ischemic stroke.
The aim is to provide an understandable picture of the clinical use of the S100B protein and give a brief overview of the current limitations that require future solutions.
Abboud, Tammam,Rohde, Veit,Mielke, Dorothee, 2023, Mini review: Current status and perspective of S100B protein as a biomarker in daily clinical practice for diagnosis and prognosticating of clinical outcome in patients with neurological diseases with focus on acute brain injury, BioMed Central
Shared genetic aetiology of Alzheimer’s disease and age-related macular degeneration by APOC1 and APOE genes
gene diagnostic based analysis amd ad apoe apoc1 identified genes pleiotropy
